Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dura acquires two intranasal steroid products from Syntex

May 13, 1997

Sequana and Boehringer Ingelheim expand alliance for asthma research

May 12, 1997

Bradykinin antagonists from Fujisawa

May 9, 1997

Kowa/Vrije University researchers identify potent CysLT1 receptor antagonists

May 7, 1997

FDA grants SciClone orphan drug status for CPX

May 6, 1997

Sanofi claims HLE inhibitors

May 6, 1997

Nacystelyn promising alternative to NAC for lung antioxidant therapy

May 5, 1997

Dual D2/beta2 agonists disclosed by Astra

May 5, 1997

Cortech and Ono amend research agreement

May 2, 1997

Japan Tobacco discloses cytokine inhibitors

May 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...